Skip to main content

RABEP2 293T Cell Transient Overexpression Lysate, Novus Biologicals

Bio-Techne includes Novus Biologicals | Catalog # H00079874-T01

Catalog #
Availability
Size / Price
Qty
Loading...
H00079874-T01

Key Product Details

Species

Human

Applications

Western Blot

Product Summary for RABEP2 293T Cell Transient Overexpression Lysate

Quality control test: Transient overexpression cell lysate was tested with Anti-RABEP2 antibody by Western Blots. Plasmid: pCMV-RABEP2 full-length

Product Specifications

Specificity

RABEP2 293T Cell Transient Overexpression Lysate(Denatured)

Type

293T Cell Transient Overexpression

Protein State

Denatured

Scientific Data Images for RABEP2 293T Cell Transient Overexpression Lysate

RABEP2 transfected lysate.
Lane 1: RABEP2 transfected lysate (58.74 KDa) Lane 2: Non-transfected lysate.

Formulation, Preparation, and Storage

Formulation

1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

Concentration

mg/ml

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at -80C. Avoid freeze-thaw cycles.

Background: RABEP2

RABEP2 plays a role in membrane trafficking and in homotypic early endosome fusion

Alternate Names

FLJ23282, FRA, rab GTPase-binding effector protein 2, rabaptin, RAB GTPase binding effector protein 2, Rabaptin-5 beta, Rabaptin-5beta, RABPT5B

Gene Symbol

RABEP2

Additional RABEP2 Products

Product Documents for RABEP2 293T Cell Transient Overexpression Lysate

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for RABEP2 293T Cell Transient Overexpression Lysate

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...